Xi Tan
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features (NCT06999941) | Xi Tan | 2025-04-24 |
Track Xi Tan automatically
Every clearance here is in the API, with alerts when new ones post.